
Our aim was to evaluate the optimal treatment strategy addressing cardiovascular risk in obese and zzso patients with zzso zzso syndrome zzso We planned a zzso zzso clinical zzso zzso and zzso women with zzso and impaired zzso tolerance zzso zzso zzso were enrolled in the zzso Six months of treatment with zzso zzso or oral contraceptive pills zzso were given to the zzso Group 1 were obese and receiving zzso Group 2 were obese and receiving zzso Group 3 were zzso and receiving zzso and Group 4 were zzso receiving zzso zzso homocysteine, high sensitive zzso protein zzso and zzso model assessment estimate of insulin resistance zzso were zzso zzso homocysteine, zzso and zzso were similar in obese and zzso groups before the zzso After 6 months of treatment, a significant decrease was observed in zzso homocysteine and zzso levels in Groups 1 and zzso An increase in zzso and zzso levels was observed in Groups 2 and zzso In this study, zzso treatment leads to improvement in hormonal and zzso parameters and decreases zzso and homocysteine levels possibly independent of zzso However, the use of oral zzso in obese and zzso patients with zzso with impaired zzso tolerance increases zzso and zzso levels and creates an increase in the zzso zzso 

